The following resources have been created to supplement the guidance document.
Mélanie Bédard, Erica Em Moodie, Joseph Cox, John Gill, Sharon Walmsley, Valérie Martel‑Laferrière, Curtis Cooper, Marina B Klein, Canadian Liver Journal, 2025
Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T, Int J Drug Policy
Stine Bordier Høj, Rémi Coignard‑Friedman, Aissata Sako, Catherine de Montigny, Marie‑Ève Beauchemin‑Nadeau, Robert Léandre, Nanor Minoyan, Geneviève Boyer‑Legault, Sofiane Chougar, Sara‑Kim Lamont, Julie Bruneau, Harm Reduction Journal , 2025
Lim J, Bruneau J, Platt RW, Panagiotoglou D., Drug Saf. 2025
Parker DG, Radin S, Sorlagas N, Wendt DC., Health Res. 2025
Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D., Can J Psychiatry. 2025
Ali, F., Law, J., Russell, C., Imtiaz, S., Bayoumi, A., Werb, D., Rhem, J., Front. Public Health
Bach P, Le Foll B, Davidson S, de Kiewit A, Bakouni H, Poulin G, Ghosh M, Jutras-Aswad D., Contemp Clin Trials. 2025
Nanor Minoyan, Stine Bordier Høj, Didier Jutras‑Aswad, Sarah Larney, Valérie Martel‑Laferrière, Marie‑Pierre Sylvestre, Julie Bruneau, International Journal of Mental Health and Addiction, 2025
Bastien G, McAnulty C, Sharafi H, Mahroug A, Elkrief L, Ziegler D, Dubreucq S, Juteau LC, Jutras-Aswad D., J Addict Med. 2025
Matthew Carwana, Eva Moore, Helia Shariati, Hasina Samji, Nicholas Chadi, Paediatrics & Child Health, 2025
